When carpal tunnel syndrome strikes, some of the simplest tasks - turning the key in the ignition, twisting off a lid on a jar, tying a shoe - become painful and intolerable.
Carpal tunnel syndrome is a nerve disorder that affects more than 20 million Americans, with the incidence growing at a rate of more than 10 percent per year. Treatment for carpal tunnel has ranked among the lowest in patient satisfaction surveys - with acceptable outcomes in less than 40 percent of cases.
However, a new therapy can provide relief from symptoms without invasive procedures. Carpal Solution Therapy was developed by Dr. Clyde E. Morgan Jr., a muscular skeletal specialist, while working with his wife to help her get control of her debilitating carpal tunnel symptoms.
Based on his firsthand experience with patients, Morgan developed a simple device to consistently decompress and retrain the soft connective tissue around the carpal tunnel, relieving pressure on the median nerve and enhancing blood circulation. Worn during sleep, the brace gently tugs simultaneously at three key points on the palm, reshaping soft tissue surrounding the carpal tunnel.
This consistent pulling action, applied for eight hours while the hand is completely relaxed, allows the body's healing process to proceed naturally, eliminating the pain and symptoms of carpal tunnel syndrome without side effects or the risk of surgery.
After Morgan's wife fully recovered from her symptoms, he applied the therapy to his patients with remarkable success. More than 95 percent reported significant relief from pain and numbness.
Morgan then submitted his device to a Medical Invention Review sponsored by Eureka Medical's Expert Advisory Board for physician inventors (www.eurekamed.com). After thorough review by a panel of experts in medicine and life sciences, Eureka awarded Morgan and Carpal Solution Therapy its top award for home health care products.
"This type of product lowers the cost of health care delivery and improves the patient outcome by catching the syndrome early and addressing it proactively at the source," said professor Clayton Christensen, Eureka co-founder and thought leader on innovation at Harvard Business School. "These types of innovations will be critical to controlling the spiraling cost of health care."
For more information, visit www.mycarpaltunnel.com or call (781) 418-6340. - NU |
|
